KOBAYASHI PHARMACEUTICAL CO.,LTD.
小林製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4967
FY2025 · 2025-12-31
| Gross margin | 51.1% |
| Operating margin | 9.0% |
| Net margin | 2.2% |
| Return on equity | 2.0% |
| Return on assets | 1.3% |
| Revenue growth (YoY) | 0.1% |
| EPS (basic) | ¥49.19 |
| EPS growth (YoY) | -63.7% |
| Current ratio | 2.47x |
| Equity ratio | 66.6% |
| Book value / share | ¥2,827.68 |
| Free cash flow | 12,337 M |